The Client is a is a Japanese CRO that is conducting a phase III clinical study in Japan for a Software medical device ( Class III). The requested pharmacovigilance services during the conduct of the clinical study in Japan.
GRP team in Japan has significant experience in providing pharmacovigilance services in Japan according to PMDA requirements. The safety team in Japan provided the following services:
click on 'learn more' to access the full case study
Want to be updated on the Latest Regulatory Information
Follow GRP on Social Media !
In Japan, The Pharmaceuticals and Medical Devices Agency (PMDA) is the government organization in charge of reviewing drugs and medical devices, overseeing post-market safety, and providing relief for adverse health effects. The PMDA operates under the Ministry of Health, Labor, and Welfare (MHLW) .These two government organization both handle a wide range of activities, from approval reviews to post-market surveillance.